 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
|
|
|
|
Phase III, Phase II
|
|
|
|
EudraCT:2005-000805-68
NCT00354120
|
|
| |
Nonmyeloablative Stem Cell Transplant in Elderly
|
|
|
|
Phase III, Phase II
|
|
|
|
012000
NCT00382759
|
|
| |
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
|
|
|
|
Phase III, Phase II
|
|
|
|
GC P#02.01.001
NCT00469729
|
|
| |
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
|
|
|
|
Phase III, Phase II
|
|
|
|
RPCI-I-72806
I 72806, NCT00536601
|
|
| |
In-Vivo Activated T-Cell Depletion to Prevent GVHD
|
|
|
|
Phase III, Phase II
|
|
|
|
0705-20 IUCRO-0196
NCT00594308
|
|
| |
Non-Myeloablative Allogeneic HSCT From HLA Matched Related Donors for the Treatment of Low Grade B Cell Malignancies
|
|
|
|
Phase III, Phase II
|
|
|
|
F080429003
UAB-0775, NCT00714259
|
|
| |
Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
|
|
|
|
Phase III
|
|
|
|
CKTO-2000-06
HOVON-44, HOVON-44/CKVO-2000-06, EU-20042, ISRCTN95614846, NCT00012051
|
|
| |
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
|
|
|
|
Phase III
|
|
|
|
EORTC-20971
EORTC-22997, NCT00014326
|
|
| |
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
|
|
|
|
Phase III
|
|
|
|
DSHNHL-1999-1A
EU-20243, NCT00052936
|
|
| |
Total-Body Irradiation With Or Without Fludarabine Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
|
|
|
|
Phase III
|
|
|
|
FHCRC-1813.00
NCT00075478
|
|
